Insulin Action: Role of Skeletal Muscle and Insulin-Mediated Blood Flow
1 other identifier
observational
N/A
1 country
1
Brief Summary
The overall objective of this proposal is to examine the contribution of changes in total body fat, enhancement in insulin-mediated vasodilatation and enhancement in endothelium-derived nitric oxide production to the improvements in metabolic insulin action. In addition, the study will track whether these improvements are related to changes in blood pressure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 3, 2001
CompletedFirst Posted
Study publicly available on registry
July 5, 2001
CompletedJanuary 21, 2009
December 1, 2004
July 3, 2001
January 20, 2009
Conditions
Keywords
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55455, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
Arthur Leon, M.D.
Alan Blank, M.D.
Study Design
- Study Type
- observational
- Sponsor Type
- FED
Study Record Dates
First Submitted
July 3, 2001
First Posted
July 5, 2001
Last Updated
January 21, 2009
Record last verified: 2004-12